Potential Treatment for Cystic Fibrosis Displays Encouraging Interim Data
DarkoStojanovic / Pixabay

Potential Treatment for Cystic Fibrosis Displays Encouraging Interim Data

According to a story from Drug Development Technology, the drug developer Translate Bio has recently reported interim results from its phase 1/2 clinical trial. This trial is testing the company's…

Continue Reading Potential Treatment for Cystic Fibrosis Displays Encouraging Interim Data
Using The Microbiome to Treat Disease: Great Potential, But Patients Must be Protected
allinonemovie / Pixabay

Using The Microbiome to Treat Disease: Great Potential, But Patients Must be Protected

According to a story from the Scientific American, new research is revealing the potential of the human microbiome as a method for treating health problems. Research is also continuing to…

Continue Reading Using The Microbiome to Treat Disease: Great Potential, But Patients Must be Protected
These Amyotrophic Lateral Sclerosis Advocates are Tired of Waiting for Progress
StockSnap / Pixabay

These Amyotrophic Lateral Sclerosis Advocates are Tired of Waiting for Progress

According to a story from True Viral News, anyone who has tried to get something done through governmental means are probably familiar with getting rebuffed and redirected at every turn.…

Continue Reading These Amyotrophic Lateral Sclerosis Advocates are Tired of Waiting for Progress

Researchers Find Success in Precision Cutting as a Exciting New Treatment for Inflammatory Bowel Disease

As reported in EurekAlert, an exciting new treatment method has entered the conversation to treat inflammatory bowel disease (IBD). Researchers have successfuly used mice population to show that precision cutting…

Continue Reading Researchers Find Success in Precision Cutting as a Exciting New Treatment for Inflammatory Bowel Disease
Phase 2a Trial of Experimental Pulmonary Arterial Hypertension Drug Begins
source: pixabay.com

Phase 2a Trial of Experimental Pulmonary Arterial Hypertension Drug Begins

According to a story from BioSpace, the biopharmaceutical company Altavant Sciences has recently announced that the first patient has been dosed in a phase 2a proof of concept trial. This…

Continue Reading Phase 2a Trial of Experimental Pulmonary Arterial Hypertension Drug Begins

Rare Disease Groups Come Together to Advocate for Newborn Screening Legislation 

Groups like Cure SMA, the Cystic Fibrosis Foundation, the Muscular Dystrophy Association, Parent Project Muscular Dystrophy (PPMD), and the National Organization for Rare Disorders (NORD) have a mission: The United States Senate…

Continue Reading Rare Disease Groups Come Together to Advocate for Newborn Screening Legislation 

This Time a “First-of-its-Kind” Study is “Out of this World” on Board the Space Station

  As reported recently in PhysOrg by NASA, researchers aboard SpaceX CRS-18 cargo flight are focusing on what triggers Parkinson’s disease and multiple sclerosis, both neurodegenerative diseases. Researchers suspect that…

Continue Reading This Time a “First-of-its-Kind” Study is “Out of this World” on Board the Space Station
Close Menu